XT
TARA icon

XTX Topco’s Protara Therapeutics TARA Stock Holding History

XTX Topco’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$244K Buy
63,948
+5,147
+9% +$24.5K ﹤0.01% 3088
2026
Q1 		$306K Sell
58,801
-56,562
-49% -$335K 0.01% 2466
2025
Q4 		$615K Buy
+115,363
New +$641K 0.02% 1418
2025
Q1 		– Sell
-11,740
Closed -$62K – 3089
2024
Q4 		$62K Sell
11,740
-20,942
-64% -$67.7K 0.01% 1861
2024
Q3 		$59.8K Buy
+32,682
New +$67.1K ﹤0.01% 1669

Other funds holding TARA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

XTX Topco's TARA Position: Q2 2026 in Review

XTX Topco increased its Protara Therapeutics (TARA) stake by 8.8% in Q2 2026, buying an estimated $24.5K and bringing the position to 63,948 shares worth $244K. The position accounts for ﹤0.01% of the portfolio, ranked #3088.

XTX Topco first reported a position in TARA in Q3 2024 and has held it in 5 quarters since. The position peaked at $615K in Q4 2025. 119 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

  • XTX Topco held 63,948 shares of Protara Therapeutics worth $244K as of Q2 2026.
  • XTX Topco bought 5,147 Protara Therapeutics shares in Q2 2026, an estimated $24.5K.
  • Protara Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3088 holding.
  • XTX Topco first reported a position in Protara Therapeutics in Q3 2024 and has held it in 5 quarters since.
  • XTX Topco's Protara Therapeutics position peaked at $615K in Q4 2025.
  • 119 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.